Navigation Links
New Technique For Benign Breast Tumors

Each year, more than 1 million women in the United States undergo breast biopsies. In about 80 percent of these cases, the lumps are benign, //or non-cancerous. But that benign lump still causes anxiety in many women. Now, one technique is making it easier for women to get rid of the lumps without surgery.

In most cases, benign breast tumors can be left alone. However though one can 99 percent sure that it is completely benign, but there is still that 1 percent to 2 percent chance that it can be malignant hence people don't want to take that risk.

In the past, doctors had to perform invasive surgery to remove the lump. But now, they can freeze it with a procedure called cryoablation. Doctors insert a probe into the tumor. Argon gas is passed through the probe to form an ice ball, which destroys the tumor. The body eventually absorbs it. The procedure takes about 30 minutes to 45 minutes and can be performed a few weeks after a biopsy.

Specialists say its an office-based procedure and the patient does not require to go to the operating room. Besides being tolerated very well it does not have a surgical scar. Thus most women prefer this as a better option.

This technique is also used to freeze liver, prostate and kidney tumors, and researchers are now testing its feasibility on breast tumors that are cancerous.
'"/>




Page: 1

Related medicine news :

1. New Laser Techniques cure degeneration of the eye
2. New Technique to Study Infants Brain.
3. Preventing Strokes Using Less Invasive Techniques
4. New Technique To Detect Activity Of Drugs In The Body
5. New Technique To Test Stem Cells That Heal The Heart
6. A New Technique For Prediction Of Adult Height
7. Novel Technique For Targeting Small-Cell Lung Cancer
8. Novel Technique For Management Of Inverted Papilloma Of Frontal Sinus
9. New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins
10. New Technique Enables Better Nursing Of Robin Sequence Infants
11. Novel Technique Can Enhance Stem Cell Multiplication By 30 Fold
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... ... services, is proud to announce the guest speaker lineup* for its second annual ... Alliance of Healthcare Purchaser Coalitions; Dr. Keith Fernandez of Privia Health; and Lisa ...
(Date:6/28/2017)... Park, IL (PRWEB) , ... June 28, 2017 , ... David B. Sosin, ... Orland Park, Illinois, took over the post of 2nd Vice President for the Illinois ... Sosin was installed as the ISBA’s 3rd Vice President in 2016 following a state-wide election ...
(Date:6/28/2017)... ... , ... Park Systems , a leader in Atomic Force Microscopy (AFM) ... and Park customers on July 11, 2017 from 12-2pm at the Thirsty Bear Brewing ... of Park Systems, and Prof. Krishna Saraswat , Rickey/Nielsen Professor in the School ...
(Date:6/28/2017)... , ... June 28, 2017 , ... ... County and the surrounding regions access to insurance assistance and financial planning services, ... 25: Ministries to assist families in the region facing financial crisis. , Matthew ...
(Date:6/27/2017)... Fla. (PRWEB) , ... June 27, 2017 , ... ... today announced the appointment of Mike Finnegan to the position of Executive Vice ... years of experience in healthcare technology, telehealth and medical device sales leadership. He ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), ... sale and distribution of the AeroForm® Tissue Expander System, ... commercial roll-out in the United States ... hundred (100) medical institutions and health systems, located throughout ... alternative for women who choose reconstructive surgery following a ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: